MX2015016721A - Metodo de pronostico en cancer de mama. - Google Patents
Metodo de pronostico en cancer de mama.Info
- Publication number
- MX2015016721A MX2015016721A MX2015016721A MX2015016721A MX2015016721A MX 2015016721 A MX2015016721 A MX 2015016721A MX 2015016721 A MX2015016721 A MX 2015016721A MX 2015016721 A MX2015016721 A MX 2015016721A MX 2015016721 A MX2015016721 A MX 2015016721A
- Authority
- MX
- Mexico
- Prior art keywords
- hsa
- mir
- breast cancer
- cancer prognosis
- prognosis method
- Prior art date
Links
- 206010006187 Breast cancer Diseases 0.000 title abstract 3
- 208000026310 Breast neoplasm Diseases 0.000 title abstract 3
- 238000004393 prognosis Methods 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 108091070501 miRNA Proteins 0.000 abstract 2
- 239000002679 microRNA Substances 0.000 abstract 2
- 108091069086 Homo sapiens miR-127 stem-loop Proteins 0.000 abstract 1
- 108091069517 Homo sapiens miR-224 stem-loop Proteins 0.000 abstract 1
- 108091070373 Homo sapiens miR-24-1 stem-loop Proteins 0.000 abstract 1
- 108091067570 Homo sapiens miR-372 stem-loop Proteins 0.000 abstract 1
- 108091063772 Homo sapiens miR-589 stem-loop Proteins 0.000 abstract 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
La presente invención se refiere a métodos útiles para determinar el pronóstico de un individuo diagnosticado con cáncer de mama, mediante la determinación del nivel de expresión de una firma de miRNAs asociados al fenotipo troncal en células de cáncer de mama que comprende miRNAs hsa-miR-224, hsa-miR-372, hsa-miR-10b, hsa-miR-548a, hsa-miR-589, hsa-miR-127, hsa-miR-133a, hsa-miR-135b y hsa-miR-189/hsa-miR-24-1 o un subconjunto de la misma, su comparación con perfiles de expresión tipo de dicha firma y el cálculo del pronóstico.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2015016721A MX390160B (es) | 2015-12-04 | 2015-12-04 | Método de pronóstico en cáncer de mama. |
| PCT/MX2016/000119 WO2017095213A1 (es) | 2015-12-04 | 2016-11-23 | Método de pronóstico en cáncer de mama |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2015016721A MX390160B (es) | 2015-12-04 | 2015-12-04 | Método de pronóstico en cáncer de mama. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2015016721A true MX2015016721A (es) | 2017-06-05 |
| MX390160B MX390160B (es) | 2025-03-20 |
Family
ID=58797455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015016721A MX390160B (es) | 2015-12-04 | 2015-12-04 | Método de pronóstico en cáncer de mama. |
Country Status (2)
| Country | Link |
|---|---|
| MX (1) | MX390160B (es) |
| WO (1) | WO2017095213A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109913551A (zh) * | 2019-03-26 | 2019-06-21 | 深圳大学 | 乳腺癌分型的核酸组合物、乳腺癌分型试剂盒及其使用方法 |
| AU2024314529A1 (en) | 2023-06-22 | 2025-12-18 | Fondazione Di Religione E Di Culto "Casa Sollievo Della Sofferenza" - Opera Di San Pio Da Pietrelcina | Prognostic method for non-metastatic female breast cancer |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103866018B (zh) * | 2005-08-01 | 2016-05-25 | 俄亥俄州立大学研究基金会 | 用于乳腺癌的诊断、预后和治疗的基于MicroRNA的方法和组合物 |
| CA2866052A1 (en) * | 2012-01-20 | 2013-07-25 | The Ohio State University | Breast cancer biomarker signatures for invasiveness and prognosis |
-
2015
- 2015-12-04 MX MX2015016721A patent/MX390160B/es unknown
-
2016
- 2016-11-23 WO PCT/MX2016/000119 patent/WO2017095213A1/es not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| MX390160B (es) | 2025-03-20 |
| WO2017095213A1 (es) | 2017-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2017007535A (es) | Sistema y metodos para derivar biomarcadores de firmas geneticas de la respuesta a antagonistas de muerte programada 1 (pd-1). | |
| SG10201908277TA (en) | Method of determining the risk of developing breast cancer by detecting the expression levels of micrornas (mirnas) | |
| MX2016011612A (es) | Determinacion de agresividad, pronostico y responsividad del cancer al tratamiento. | |
| MX2022015737A (es) | Compuestos para mejorar el empalme del acido ribonucleico mensajero (arnm). | |
| MX2019002425A (es) | Micro ácidos ribonucleicos como biomarcadores para la endometriosis. | |
| GB2513732A (en) | Methods and compositions for sample identification | |
| MY176706A (en) | Biomarkers and methods of treating pd-1 and pd-l1 related conditions | |
| WO2013006495A3 (en) | Methods of predicting prognosis in cancer | |
| MX341840B (es) | Biomarcadores de microarn indicativos de la enfermedad de alzheimer. | |
| GB201216076D0 (en) | Methods for obtaining a sequence | |
| MX2021009297A (es) | Composiciones, dispositivos, y metodos de pruebas de sensibilidad del ibs. | |
| NZ629555A (en) | Monocyte biomarkers for cancer detection | |
| WO2013107459A3 (en) | Microrna for diagnosis of pancreatic cancer and/or prognosis of patients with pancreatic cancer by blood samples | |
| TN2013000464A1 (en) | Biomarkers for hedgehog inhibitor therapy | |
| EP4495936A3 (en) | Systems and methods for determining copy number variation | |
| WO2014121239A3 (en) | Multiplexed digital assay with data exclusion for calculation of target levels | |
| MX2010004917A (es) | Proceso para monitorear el cancer colorrectal. | |
| EP3798316A3 (en) | Genes and gene signatures for diagnosis and treatment of melanoma | |
| NZ730124A (en) | A method of predicting risk of recurrence of cancer | |
| NZ701652A (en) | Breast cancer prognosis, prediction of progesterone receptor subtype and|prediction of response to antiprogestin treatment based on gene expression | |
| MX2018006523A (es) | Tecnicas para asignacion de asuntos. | |
| WO2019094780A3 (en) | Non-coding rna for detection of cancer | |
| AU2016250096A8 (en) | Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features | |
| WO2014187884A3 (en) | Mirnas as non-invasive biomarkers for heart failure | |
| EP4265740A3 (en) | Methods for predicting risk of metastasis in cutaneous melanoma |